3 news items
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
ALAR
AMIX
ASNS
18 Jun 24
after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
ZNTL
18 Jun 24
like azenosertib. We look forward to sharing these results along with overall efficacy and safety data from DENALI Cohort 1b later this year
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting
ZNTL
23 May 24
and Conclusions: 31 patients were enrolled in the study, of which 31 were evaluable for safety, 29 were evaluable for dose
- Prev
- 1
- Next